Gleason Group Inc. lessened its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 8.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 17,787 shares of the company’s stock after selling 1,711 shares during the period. Procter & Gamble comprises about 0.5% of Gleason Group Inc.’s holdings, making the stock its 19th largest holding. Gleason Group Inc.’s holdings in Procter & Gamble were worth $2,982,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently bought and sold shares of the stock. Itau Unibanco Holding S.A. bought a new position in Procter & Gamble in the second quarter worth about $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $29,000. RPg Family Wealth Advisory LLC purchased a new position in shares of Procter & Gamble in the 3rd quarter valued at approximately $33,000. Quest Partners LLC purchased a new stake in Procter & Gamble in the second quarter worth $36,000. Finally, Fairfield Financial Advisors LTD bought a new position in Procter & Gamble in the second quarter worth $44,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Trading Up 0.2 %
Shares of NYSE PG opened at $158.86 on Tuesday. The Procter & Gamble Company has a 1-year low of $146.28 and a 1-year high of $180.43. The business has a fifty day moving average price of $169.52 and a 200 day moving average price of $169.55. The stock has a market capitalization of $374.12 billion, a P/E ratio of 27.39, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.
Insider Buying and Selling at Procter & Gamble
In other news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 75,439 shares of company stock valued at $13,317,460. 0.18% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on PG. Morgan Stanley increased their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Evercore ISI upped their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Piper Sandler began coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective on the stock. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Finally, Wells Fargo & Company lowered their price target on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $179.75.
View Our Latest Stock Analysis on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- What is the S&P 500 and How It is Distinct from Other Indexes
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What Investors Need to Know to Beat the Market
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.